Oxidative stress in kidney transplantation causes, consequences, and potential treatment

Iranian Journal of Kidney Diseases

Volumn 5, Issue 6, 2011, Pages 357-372

  Nafar, Mohsen ^a   Sahraei, Zahra ^b   Salamzadeh, Jamshid ^b   Samavat, Shiva ^a   Vaziri, Nosartolah D ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kidney failure; Kidney transplantation; Oxidative stress; Reperfusion injury

Indexed keywords

ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CARBON MONOXIDE; CARVEDILOL; CREATININE; DNA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MELAGATRAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NUCLEIC ACID; OXIDIZING AGENT; PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ACUTE GRAFT REJECTION; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DNA FRAGMENTATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LONG TERM CARE; METABOLIC SYNDROME X; NEOPLASM; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; RISK FACTOR; SINGLE DRUG DOSE;

ANTIOXIDANTS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 80755172641     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Cottone S, Palermo A, Vaccaro F, et al. In renal transplanted patients inflammation and oxidative stress are interrelated. Transplant Proc. 2006;38:1026-30.
2. Juskowa J, Paczek L, Laskowska-Klita T, Rancewicz Z, Gajewska J, Jedynak-Oldakowska U. [Selected parameters of antioxidant capacity in renal allograft recipients]. Pol Arch Med Wewn. 2001;105:19-27. Polish.
3. Barakat N, Hussein AA, Abdel-Maboud M, El-Shair MA, Mostafa A, Abol-Enein H. Ischaemia-reperfusion injury in renal transplantation: the role of nitric oxide in an experimental rat model. BJU Int. 2010;106:1230-6.
4. Aveles PR, Criminacio CR, Goncalves S, et al. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract. 2010;116:c294-9.
5. Kamgar M, Zaldivar F, Vaziri ND, Pahl MV. Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. J Natl Med Assoc. 2009;101:336-44.
6. Pawlak K, Pawlak D, Mysliwiec M. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Clin Biochem. 2007;40:81-5.
7. Simmons EM, Langone A, Sezer MT, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914-9.
8. Kocak H, Ceken K, Yavuz A, et al. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol Dial Transplant. 2006;21:203-7.
9. Vural A, Yilmaz MI, Caglar K, et al. Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol. 2005;25:250-5.
10. Perrea DN, Moulakakis KG, Poulakou MV, Vlachos IS, Papachristodoulou A, Kostakis AI. Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function. Int Urol Nephrol. 2006;38:343-8.
11. Favreau F, Petit-Paris I, Hauet T, et al. Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion. Free Radic Biol Med. 2004;36:1034-42.
12. Minz M, Heer M, Arora S, Sharma A, Khullar M. Oxidative status in stable renal transplantation. Transplant Proc. 2006;38:2020-1.
13. Zahmatkesh M, Kadkhodaee M, Mahdavi-Mazdeh M, et al. Oxidative stress status in renal transplant recipients. Exp Clin Transplant. 2010;8:38-44.
14. Kosieradzki M, Kuczynska J, Piwowarska J, et al. Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation. 2003;75:1221-7.
15. Kosieradzki M, Rowinski W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 2008;40:3279-88.
16. Morales-Indiano C, Lauzurica R, Pastor MC, et al. Greater posttransplant inflammation and oxidation are associated with worsening kidney function in patients with pretransplant diabetes mellitus. Transplant Proc. 2009;41:2126-8.
17. Osorio Moratalla JM, Ferreyra Lanatta C, Baca Morilla Y, et al. Left ventricular structure and function in long- term kidney transplantation: the influence of glucose metabolism and oxidative stress. Transplant Proc. 2008;40:2912-5.
18. Montanaro D, Gropuzzo M, Tulissi P, et al. [Cardiovascular disease after renal transplantation]. G Ital Nefrol. 2004;21 Suppl 26:S53-66. Italian.
19. Ott U, Aschoff A, Funfstuck R, Jirikowski G, Wolf G. DNA fragmentation in acute and chronic rejection after renal transplantation. Transplant Proc. 2007;39:73-7.
20. Van Hoek F, Van Tits HW, Van Lijnschoten I, De Haas BD, Scheltinga MR. Multiple carcinomas in the hemodialysis access induced ischemic hand of a renal transplant patient. Eur J Dermatol. 2010;20:214-6.
21. Cooke MS, Osborne JE, Singh R, et a l. Evidence that oxidative stress is a risk factor for the development of squamous cell carcinoma in renal transplant patients. Free Radic Biol Med. 2007;43:1328-34.
22. Fekecs T, Kadar Z, Battyani Z, et al. Changes in oxidative stress in patients screened for skin cancer after solid-organ transplantation. Transplant Proc. 2010;42:2336-8.
23. Aiello S, Cassis P, Mister M, et al. Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation. Transpl Int. 2011;24:829-38.
24. Danilovic A, Lucon AM, Srougi M, et al. Protective effect of N-acetylcysteine on early outcomes of deceased renal transplantation. Transplant Proc. 2011;43:1443-9.
25. Tain YL, Muller V, Szabo A, Dikalova A, Griendling K, Baylis C. Lack of long-term protective effect of antioxidant/anti-inflammatory therapy in transplant-induced ischemia/ reperfusion injury. Am J Nephrol. 2006;26:213-7.
26. Raj DS, Lim G, Levi M, Qualls C, Jain SK. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy. Am J Kidney Dis. 2004;43:154-60.
27. Djamali A. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J. Physiol Renal Physiol. 2007;293:F445-55.
28. Ha H, Park J, Kim YS, Endou H. Oxidative stress and chronic allograft nephropathy. Yonsei Med J. 2004;45:1049-52.
29. Kim JH, Park J, Ha H. Increased intracellular reactive oxygen species in peripheral blood mononuclear cells from renal transplant recipients with decreased graft function. J Korean Soc Transplant. 2003;17:131-6.
30. Cottone S, Palermo A, Vaccaro F, Vadala A, Buscemi B, Cerasola G. Oxidative stress and inflammation in long-term renal transplanted hypertensives. Clin Nephrol. 2006;66:32-8.
31. Cristol JP, Vela C, Maggi MF, Descomps B, Mourad G. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation. 1998;65:1322-8.
32. Osorio JM, Ferreyra C, Perez A, Moreno JM, Osuna A. Prediabetic States, subclinical atheromatosis, and oxidative stress in renal transplant patients. Transplant Proc. 2009;41:2148-50.
33. Ruiz MC, Medina A, Moreno JM, et al. Relationship between oxidative stress parameters and atherosclerotic signs in the carotid artery of stable renal transplant patients. Transplant Proc. 2005;37:3796-8.
34. Reinders ME, Rabelink TJ, Briscoe DM. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol. 2006;17:932-42.
35. Land WG. Ageing and immunosuppression in kidney transplantation. Exp Clin Transplant. 2004;2:229-37.
36. Antolini F, Valente F, Ricciardi D, Baroni M, Fagugli RM. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta. 2005;358:87-94.
37. Waller HL, Harper SJ, Hosgood SA, et al. Biomarkers of oxidative damage to predict ischaemia-reperfusion injury in an isolated organ perfusion model of the transplanted kidney. Free Radic Res. 2006;40:1218-25.
38. Simic-Ogrizovic S, Simic T, Reljic Z, et al. Markers of oxidative stress after renal transplantation. Transpl Int. 1998;11 Suppl 1:S125-9.
39. Matsuyama Y, Terawaki H, Terada T, Era S. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Clin Exp Nephrol. 2009;13:308-15.
40. Joo DJ, Huh KH, Cho Y, et al. Change in serum lipid peroxide as an oxidative stress marker and its effects on kidney function after successful kidney transplantation. Transplant Proc. 2010;42:729-32.
41. Chmiel B, Kusmierski S, Kokocinska D, Cierpka L. [Serum lipofuscin level after renal transplantation]. Przegl Lek 2003;60:21-3. Polish.
42. Domanski L, Safranow K, Dolegowska B, et al. Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans. Transplant Proc. 2006;38:35-8.
43. Matsumoto S, Hanai T, Matsuura T, Uemura H, Nishioka T, Akiyama T. Can monitoring of serum 8-OHdG level for 2 hours after renal transplantation predict prognosis of the graft? Transplant Proc. 2006;38:2014-5.
44. Makropoulos W, Kocher K, Heintz B, Schwarz ER, Mertens PR, Stefanidis I. Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Ren Fail. 2000;22:499-510.
45. Matsumoto S, Hanai T, Matsuura T, Uemura H, Nishioka T, Akiyama T. Creatol, an oxidative product of creatinine in kidney transplant patients, as a useful determinant of renal function: a preliminary study. Transplant Proc. 2006;38:2009-11.
46. Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA. Gas- generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation. 1996;61:93-8.
47. Yates PJ, Hosgood SA, Nicholson ML. A Biphasic Response to Nitric Oxide Donation in an Ex Vivo Model of Donation After Cardiac Death Renal Transplantation. J Surg Res. 2011.
48. Bellos JK, Perrea DN, Theodoropoulou E, Vlachos I, Papachristodoulou A, Kostakis AI. Clinical correlation of nitric oxide levels with acute rejection in renal transplantation. Int Urol Nephrol. 2011;43:883-90.
49. Oehlschlager S, Albrecht S, Hakenberg OW, et al. Measurement of free radicals and NO by chemiluminescence to identify the reperfusion injury in renal transplantation. Luminescence. 2002;17:130-2.
50. Snoeijs MG, van Bijnen A, Swennen E, et al. Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation. Ann Surg. 2011;253:598-604.
51. Lauzurica R, Pastor MC, Bayes B, et al. F2-isoprostanes in kidney transplant patients: relationship with inflammatory markers. Transplant Proc. 2005;37:3842-3.
52. de Vries DK, Lindeman JH, Tsikas D, et al. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant. 2009;9:1574-84.
53. Caban A, Budzinski G, Oczkowicz G, Suszka-Switek A, Dec R, Cierpka L. Factors determining changes in concentrations of pro-inflammatory markers in blood serum in the initial period after kidney transplantation from dead donor. Ann Transplant. 2009;14:10-3.
54. Sancho A, Pastor MC, Bayes B, et al. Posttransplant inflammation associated with onset of chronic kidney disease. Transplant Proc. 2010;42:2896-8.
55. Grebe SO, Kuhlmann U, Fogl D, Luyckx VA, Mueller TF. Macrophage activation is associated with poorer long-term outcomes in renal transplant patients. Clin Transplant. 2010.
56. De Vega L, Perez Fernandez R, Martin Mateo MC, et al. Study of the activity of glutathione-peroxidase, glutathione-transferase, and glutathione-reductase in renal transplants. Transplant Proc. 2003;35:1346-50.
57. Aguilar A, Alvarez-Vijande R, Capdevila S, Alcoberro J, Alcaraz A. Antioxidant patterns (superoxide dismutase, glutathione reductase, and glutathione peroxidase) in kidneys from non-heart-beating-donors: experimental study. Transplant Proc. 2007;39:249-52.
58. Masztalerz M, Wlodarczyk Z, Czuczejko J, Slupski M, Kedziora J. Superoxide anion as a marker of ischemiareperfusion injury of the transplanted kidney. Transplant Proc. 2006;38:46-8.
59. Whitin JC, Tham DM, Bhamre S, et al. Plasma glutathione peroxidase and its relationship to renal proximal tubule function. Mol Genet Metab. 1998;65:238-45.
60. Zachara BA, Wlodarczyk Z, Masztalerz M, Adamowicz A, Gromadzinska J, Wasowicz W. Selenium concentrations and glutathione peroxidase activities in blood of patients before and after allogenic kidney transplantation. Biol Trace Elem Res. 2004;97:1-13.
61. Cruthirds DL, Novak L, Akhi KM, Sanders PW, Thompson JA, MacMillan-Crow LA. Mitochondrial targets of oxidative stress during renal ischemia/reperfusion. Arch Biochem Biophys. 2003;412:27-33.
62. Martin Mateo MC, Herreros C, Melero R, Bustamante J. Isolation, characterization, and evaluation of metallothionein in renal transplant patients. Ren Fail. 2003;25:719-25.
63. Dolegowska B, Blogowski W, Domanski L. Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. J Am Coll Surg. 2010;211:587-95.
64. Schmitz V, Klawitter J, Bendrick-Peart J, et al. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation. Nephron Exp Nephrol. 2009;111:e80-91.
65. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 2005;67:1142-51.
66. Muhlberger I, Perco P, Fechete R, Mayer B, Oberbauer R. Biomarkers in renal transplantation ischemia reperfusion injury. Transplantation. 2009;88:S14-9.
67. Wang L, Kamijo Y, Matsumoto A, et al. Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count. Glycoconj J. 2011;28:125-35.
68. Baumann M, Caron M, Schmaderer C, et al. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation. Transplantation. 2008;86:330-5.
69. Djamali A, Sadowski EA, Muehrer RJ, et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol. 2007;292:F513-22.
70. Fernandes Bertocchi AP, Campanhole G, Wang PH, et al. A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int. 2008;21:999-1007.
71. Hoogland ER, Snoeijs MG, van Heurn LW. DCD kidney transplantation: results and measures to improve outcome. Curr Opin Organ Transplant. 2010;15:177-82.
72. Morozumi J, Matsuno N, Sakurai E, Nakamura Y, Arai T, Ohta S. Application of an automated cardiopulmonary resuscitation device for kidney transplantation from uncontrolled donation after cardiac death donors in the emergency department. Clin Transplant. 2010;24:620-5.
73. Lee JI, Son HY, Kim MC. Attenuation of ischemia- reperfusion injury by ascorbic acid in the canine renal transplantation. J Vet Sci. 2006;7:375-9.
74. van der Woude FJ, Schnuelle P, Yard BA. Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J Investig Med. 2004;52:323-9.
75. Altan H, Bozkurt AK, Arslan C, Ustundag N, Konukoglu D, Koksal C. Serine protease inhibitor aprotinin ameliorates renal injury in a rat model of ischemia-perfusion injury. Transplant Proc. 2009;41:1512-6.
76. Dobashi K, Singh I, Orak JK, Asayama K, Singh AK. Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia- reperfusion injury in rat kidney. Mol Cell Biochem. 2002;240:9-17.
77. Yaguas K, Bautista R, Quiroz Y, et al. Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension. Am J Nephrol. 2010;31:283-91.
78. Marx A, Heberer M, Jorgensen J, Gurke L, Mihatsch M, Landmann J. [Donor allopurinol treatment improves organ preservation of the kidney also when using UW solution]. Helv Chir Acta. 1992;58:911-4. German.
79. Loong CC, Chang YH, Wu TH, et al. Antioxidant supplementation may improve renal transplant function: a preliminary report. Transplant Proc. 2004;36:2438-9.
80. Treska V, Kobr J, Hasman D, et al. Ischemia-reperfusion injury in kidney transplantation from non-heart-beating donor--do antioxidants or antiinflammatory drugs play any role? Bratisl Lek Listy. 2009;110:133-6.
81. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, McDonald JR, Walker RJ. Vitamin C improves endothelial dysfunction in renal allograft recipients. Nephrol Dial Transplant. 2001;16:1251-5.
82. Blackhall ML, Fassett RG, Sharman JE, Geraghty DP, Coombes JS. Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients. Nephrol Dial Transplant. 2005;20:1970-5.
83. Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol. 2009;297:F106-13.
84. Cho KH, Kim HJ, Kamanna VS, Vaziri ND. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys Acta. 2010;1800:6-15.
85. Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez- Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol. 2008;294:F336-44.
86. Schnell-Inderst P, Kossmann B, Fischereder M, Klauss V, Wasem J. Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure. GMS Health Technol Assess. 2006; 2:Doc14.
87. Klooster A, Leuvenink HG, Gans RO, Bakker SJ. Tissue thiamine deficiency as potential cause of delayed graft function after kidney transplantation: thiamine supplementation of kidney donors may improve transplantation outcome. Med Hypotheses. 2007;69:873-8.
88. Teplan V, Schuck O, Stollova M, Vitko S. Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant. 2003;18 Suppl 5:v71-3.
89. Manrique J, Diaz A, Gavira JJ, Hernandez A, Pujante D, Errasti P. Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation. Transplant Proc. 2005;37:3782-4.
90. Nafar M, Khatami F, Kardavani B, et al. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp Clin Transplant. 2009;7:33-9.
91. Ivanovski N, Stojceva-Taneva O, Grozdanovski R, Boskovska M, Drueke TB, Massy ZA. Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment. Nephrologie. 2004;25:301-3.
92. Xu T, Wang XF, Qu XK, et al. [Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]. Zhonghua Wai Ke Za Zhi. 2005;43:940-3. Chinese.
93. Dlugosz A, Kuzniar J, Sawicka E, et al. Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients. Int Urol Nephrol. 2004;36:253-8.
94. Favreau F, Thuillier R, Cau J, et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant. 2010;10:30-9.
95. Hayashi T, De Velasco MA, Saitou Y, et al. Carvedilol protects tubular epithelial cells from ischemiareperfusion injury by inhibiting oxidative stress. Int J Urol. 2010;17:989-95.
96. Zezina L, Vessby B, Larsson E, Backman U, Fellstrom B. Carvedilol treatment of kidney graft recipients with chronic rejection. Clin Transplant. 1999;13:484-90.
97. Calo L, Giacon B, Davis PA, et al. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine. Clin Nephrol. 2002;58:103-10.
98. Padi SS, Chopra K. Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol. Nephron. 2002;92:685-92.
99. Gandhi C, Zalawadia R, Balaraman R. Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats. Ren Fail. 2008;30:921-30.
100. el-Agroudy AE, Hassan NA, Foda MA, et al. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol. 2003;23:300-6.
101. Chander V, Singh D, Tirkey N, Chander H, Chopra K. Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist. Ren Fail. 2004;26:467-77.
102. Calo LA, Davis PA, Giacon B, et al. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol. 2002;40:625-31.
103. Xu L, Han F, Mandal A, Rao GN, Zhang X. Diazoxide attenuates hypothermic preservation-induced renal injury via down-regulation of CHOP and caspase-12. Nephrol Dial Transplant. 2010;25:3859-67.
104. Shimizu S, Saito M, Kinoshita Y, et al. Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br J Pharmacol. 2011;163:272-82.
105. Ruiz MC, Moreno JM, Ruiz N, Vargas F, Asensio C, Osuna A. Effect of statin treatment on oxidative stress and renal function in renal transplantation. Transplant Proc. 2006;38:2431-3.
106. Ruiz Fuentes MC, Moreno Ayuso JM, Ruiz Fuentes N, Vargas Palomares JF, Asensio Peinado C, Osuna Ortega A. Treatment with N-acetylcysteine in stable renal transplantation. Transplant Proc. 2008;40:2897-9.
107. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res. 2006;34:41-6.
108. Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant. 1999;14:923-9.
109. Monge M, Ledeme N, Mazouz H, et al. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol Dial Transplant. 2007;22:1979-85.
110. de Vries B, Walter SJ, von Bonsdorff L, et al. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation. 2004;77:669-75.
111. Schmitz V, Klawitter J, Bendrick-Peart J, et al. Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantation. Eur Surg Res. 2006;38:388-98.
112. Korb SM, Albornoz G, Light JA. Selenium addition to the flush/preservation solution protects kidneys against oxidative stress during warm and cold ischemia. Transplant Proc. 1990;22:452-4.
113. Regner KR, Nilakantan V, Ryan RP, et al. Protective effect of Lifor solution in experimental renal ischemia-reperfusion injury. J Surg Res. 2010;164:e291-7.
114. Ahlenstiel T, Burkhardt G, Kohler H, Kuhlmann MK. Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutions. Transplantation. 2006;81:231-9.
115. Jacobsson J, Odlind B, Tufveson G, Wahlberg J. Improvement of renal preservation by adding lidoflazine to University of Wisconsin solution. An experimental study in the rat. Cryobiology. 1992;29:305-9.
116. Treska V, Kuntscher V, Molacek J, Kobr J, Racek J, Trefil L. Can ischemia-reperfusion syndrome in transplanted kidneys procured from non-heart-beating donors be influenced by adding selenium into the reperfusion solution? An experimental study. Transplant Proc. 2003;35:3125-7.
117. Desurmont T, Giraud S, Cau J, et al. Trophic factor and FR167653 supplementation during cold storage rescue chronic renal injury. J Urol. 2011;185:1139-46.
118. Mitchell T, Rotaru D, Saba H, Smith RA, Murphy MP, MacMillan-Crow LA. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. J Pharmacol Exp Ther. 2011;336:682-92.
119. Semmelmann A, Neeff H, Sommer O, Thomusch O, Hopt UT, von Dobschuetz E. Evaluation of preservation solutions by ESR-spectroscopy: superior effects of University of Wisconsin over Histidine-Tryptophan-Ketoglutarate in reducing renal reactive oxygen species. Kidney Int. 2007;71:875-81.
120. Koga H, Hagiwara S, Kusaka J, et al. New alpha-Lipoic Acid Derivative, DHL-HisZn, Ameliorates Renal Ischemia-Reperfusion Injury in Rats. J Surg Res. 2011.
121. Thuillier R, Favreau F, Celhay O, Macchi L, Milin S, Hauet T. Thrombin inhibition during kidney ischemia-reperfusion reduces chronic graft inflammation and tubular atrophy. Transplantation. 2010;90:612-21.
122. Azzollini N, Cugini D, Cassis P, et al. Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. Kidney Int. 2008;74:1420-8.
123. Mister M, Noris M, Szymczuk J, et al. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int. 2002;61:1064-78.
124. Huisman A, Vos I, van Faassen EE, et al. Antiinflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J. 2002;16:1135-7.
125. Schramm L, La M, Heidbreder E, et al. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int. 2002;61:1423-32.
126. Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L. L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept. 2010;161:58-66.
127. Jeon SH, Park HM, Kim SJ, et al. Taurine reduces FK506- induced generation of ROS and activation of JNK and Bax in Madin Darby canine kidney cells. Hum Exp Toxicol. 2010;29:627-33.
128. Guan X, Dei-Anane G, Liang R, et al. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. J Surg Res. 2008;146:127-34.
129. Ramezani M, Nazemian F, Shamsara J, Koohrokhi R, Mohammadpour AH. Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients. J Ren Nutr. 2011;21:196-9.
130. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol. 2009;297:F895-903.
131. Basu S, Meisert I, Eggensperger E, Krieger E, Krenn CG. Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation. Redox Rep. 2007;12:195-202.
132. Fassett RG, Healy H, Driver R, et al. Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial. BMC Nephrol. 2008;9:17.
133. Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction. Nephron Exp Nephrol. 2009;112:e31-42.
134. Yildiz F, Coban S, Terzi A, et al. Protective effects of Nigella sativa against ischemia-reperfusion injury of kidneys. Ren Fail. 2010;32:126-31.
135. Feng L, Ke N, Cheng F, et al. The protective mechanism of ligustrazine against renal ischemia/reperfusion injury. J Surg Res. 2011;166:298-305.
136. Stachowska E, Wesolowska T, Olszewska M, et al. Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients. Br J Nutr. 2005;93:345-52.
137. Nafar M, Noori N, Jalali-Farahani S, et al. Mediterranean diets are associated with a lower incidence of metabolic syndrome one year following renal transplantation. Kidney Int. 2009;76:1199-206.